Current Role of Renal Biopsy in Urologic Practice

Miki Haifler; Alexander Kutikov

doi:10.1016/j.ucl.2016.12.006

Current Role of Renal Biopsy in Urologic Practice

Miki Haifler, Alexander Kutikov

Temple University

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

Abstract

Most small renal masses (SRMs) are indolent. In fact, only approximately 80% of SRMs are malignant. Furthermore, SRMs are commonly detected in elderly and comorbid patients. Therefore, opportunities for better care intensity calibration exist. Renal mass biopsy (RMB), when appropriately used, is a valuable clinical tool to help with critical clinical decision-making in patients with SRM. This article summarizes the role of modern RMB in helping gauge care for patients with SRM.

Original language	English
Pages (from-to)	203-211
Number of pages	9
Journal	Urologic Clinics of North America
Volume	44
Issue number	2
DOIs	https://doi.org/10.1016/j.ucl.2016.12.006
State	Published - May 2017

Keywords

Accuracy
Biopsy
Diagnosis
Renal cell carcinoma
Renal mass

Access to Document

10.1016/j.ucl.2016.12.006

Cite this

@article{6d5ca10e695a4c7aa03e1a5f1257bd46,

title = "Current Role of Renal Biopsy in Urologic Practice",

abstract = "Most small renal masses (SRMs) are indolent. In fact, only approximately 80% of SRMs are malignant. Furthermore, SRMs are commonly detected in elderly and comorbid patients. Therefore, opportunities for better care intensity calibration exist. Renal mass biopsy (RMB), when appropriately used, is a valuable clinical tool to help with critical clinical decision-making in patients with SRM. This article summarizes the role of modern RMB in helping gauge care for patients with SRM.",

keywords = "Accuracy, Biopsy, Diagnosis, Renal cell carcinoma, Renal mass",

author = "Miki Haifler and Alexander Kutikov",

note = "Publisher Copyright: {\textcopyright} 2017 Elsevier Inc.",

year = "2017",

month = may,

doi = "10.1016/j.ucl.2016.12.006",

language = "English",

volume = "44",

pages = "203--211",

journal = "Urologic Clinics of North America",

issn = "0094-0143",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Current Role of Renal Biopsy in Urologic Practice

AU - Haifler, Miki

AU - Kutikov, Alexander

PY - 2017/5

Y1 - 2017/5

N2 - Most small renal masses (SRMs) are indolent. In fact, only approximately 80% of SRMs are malignant. Furthermore, SRMs are commonly detected in elderly and comorbid patients. Therefore, opportunities for better care intensity calibration exist. Renal mass biopsy (RMB), when appropriately used, is a valuable clinical tool to help with critical clinical decision-making in patients with SRM. This article summarizes the role of modern RMB in helping gauge care for patients with SRM.

AB - Most small renal masses (SRMs) are indolent. In fact, only approximately 80% of SRMs are malignant. Furthermore, SRMs are commonly detected in elderly and comorbid patients. Therefore, opportunities for better care intensity calibration exist. Renal mass biopsy (RMB), when appropriately used, is a valuable clinical tool to help with critical clinical decision-making in patients with SRM. This article summarizes the role of modern RMB in helping gauge care for patients with SRM.

KW - Accuracy

KW - Biopsy

KW - Diagnosis

KW - Renal cell carcinoma

KW - Renal mass

UR - http://www.scopus.com/inward/record.url?scp=85017444942&partnerID=8YFLogxK

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000401398100009&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1016/j.ucl.2016.12.006

DO - 10.1016/j.ucl.2016.12.006

M3 - Review article

C2 - 28411912

SN - 0094-0143

VL - 44

SP - 203

EP - 211

JO - Urologic Clinics of North America

JF - Urologic Clinics of North America

IS - 2

ER -

Current Role of Renal Biopsy in Urologic Practice

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this